Ann Marie Navar, MD, PhD

Ann Marie Navar, MD, PhD, is an associate professor in the departments of internal medicine and population and data sciences at UT Southwestern Medical Center.

Articles by Ann Marie Navar, MD, PhD

Enlicitide, Oral PCSK9 Inhibitor, Cuts LDL 60% in CORALreef Trials

ByPearl Steinzor,Ann Marie Navar, MD, PhD

September 14th 2026

Ann Marie Navar, MD, PhD, on enlicitide's 60% LDL reduction, less than 50% ApoB lowering, fasting dosing rules, and how it compares with inclisiran.

Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD

ByLaura Joszt, MA,Ann Marie Navar, MD, PhD

November 8th 2025

The oral PCSK9 inhibitor enlicitide can change cholesterol management with high efficacy and improved adherence, said Ann Marie Navar, MD, PhD.

Ann Marie Navar, MD, PhD

Articles by Ann Marie Navar, MD, PhD

Enlicitide, Oral PCSK9 Inhibitor, Cuts LDL 60% in CORALreef Trials

Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD

Latest Updated Articles

Trending on AJMC

Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD

A Patient-Centered Reconstruction of 340B in Oncology: Transparency, Equity, and Site-of-Care Accountability

FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes

Oral GLP-1s, Medicare Bridge Reshape Obesity Care: Holly Lofton, MD

Which Antibiotics Raise C. Diff Risk Most? Jason Pogue, PharmD